ZA832214B - Disubstituted polymethylene-imines,processes for their preparation and pharmaceutical compositions containing them - Google Patents

Disubstituted polymethylene-imines,processes for their preparation and pharmaceutical compositions containing them

Info

Publication number
ZA832214B
ZA832214B ZA832214A ZA832214A ZA832214B ZA 832214 B ZA832214 B ZA 832214B ZA 832214 A ZA832214 A ZA 832214A ZA 832214 A ZA832214 A ZA 832214A ZA 832214 B ZA832214 B ZA 832214B
Authority
ZA
South Africa
Prior art keywords
alkyl
hydrogen
chlorine
fluorine
imines
Prior art date
Application number
ZA832214A
Other languages
English (en)
Inventor
Gilbert Regnier
Alain Dhainaut
Michel Laubie
Jacques Duhault
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA832214B publication Critical patent/ZA832214B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ZA832214A 1982-03-30 1983-03-29 Disubstituted polymethylene-imines,processes for their preparation and pharmaceutical compositions containing them ZA832214B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8205373A FR2524467A1 (fr) 1982-03-30 1982-03-30 Polymethylene-imines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant

Publications (1)

Publication Number Publication Date
ZA832214B true ZA832214B (en) 1983-12-28

Family

ID=9272531

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA832214A ZA832214B (en) 1982-03-30 1983-03-29 Disubstituted polymethylene-imines,processes for their preparation and pharmaceutical compositions containing them

Country Status (14)

Country Link
US (1) US4514398A (xx)
EP (1) EP0090733B1 (xx)
JP (1) JPS58180482A (xx)
AT (1) ATE16286T1 (xx)
AU (1) AU559376B2 (xx)
CA (1) CA1206150A (xx)
DE (1) DE3361100D1 (xx)
ES (1) ES8405273A1 (xx)
FR (1) FR2524467A1 (xx)
IE (1) IE55223B1 (xx)
NZ (1) NZ203724A (xx)
OA (1) OA07358A (xx)
PT (1) PT76470B (xx)
ZA (1) ZA832214B (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58128002A (ja) * 1982-01-25 1983-07-30 Sony Corp 記録再生装置
FR2544315B1 (fr) * 1983-04-12 1985-07-05 Adir Polymethylene imines disubstituees, leurs procedes de preparation, et les compositions pharmaceutiques les renfermant
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
US5243047A (en) * 1988-02-15 1993-09-07 Imperial Chemical Industries Plc Triazole/thiazole amino-s-triazine bonding agents
JP2614921B2 (ja) * 1989-07-05 1997-05-28 帝人株式会社 ２，４，６―三置換―ｓ―トリアジン誘導体，及びその製造方法
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB8929022D0 (en) * 1989-12-22 1990-02-28 Ici Plc Diazine derivatives
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
FR2664594B1 (fr) * 1990-07-11 1992-09-18 Adir Polymethylene-imines disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
FR2667243B1 (fr) * 1990-09-27 1994-11-04 Adir Utilisation de s derives de la triazine et de la pyrimidine pour l'obtention de medicaments reversant la resistance aux agents anticancereux et antimalariques.
FR2673627B1 (fr) * 1991-03-07 1993-05-07 Adir Triazines et pyrimidines trisubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
AU2599992A (en) * 1991-11-12 1993-06-15 Pfizer Inc. Triazine derivatives for enhancing antitumor activity
WO1994022826A1 (en) * 1993-04-07 1994-10-13 Otsuka Pharmaceutical Co., Ltd. Peripheral vasodilating agent containing n-acylated 4-amino piperidine derivatives as active ingredients
US5919797A (en) * 1996-04-24 1999-07-06 Emory University Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites
US6943161B2 (en) * 1999-12-28 2005-09-13 Pharmacopela Drug Discovery, Inc. Pyrimidine and triazine kinase inhibitors
MY142362A (en) 2004-01-29 2010-11-30 Otsuka Pharma Co Ltd Pharmaceutical composition for promoting angiogenesis
PL2632916T3 (pl) 2010-10-27 2017-07-31 The Walter And Eliza Hall Institute Of Medical Research Nowe środki przeciwnowotworowe
WO2015090226A1 (zh) 2013-12-20 2015-06-25 中国人民解放军军事医学科学院毒物药物研究所 N，n'取代哌啶胺类化合物、其制备方法及用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL277028A (xx) * 1961-04-19
US3362221A (en) * 1964-06-30 1968-01-09 Hays Corp Magnetic flow transmitter system
US3270014A (en) * 1965-07-01 1966-08-30 Upjohn Co 1, 2-dihydro-1-hydroxy-1, 3, 5-triazines
US3576805A (en) * 1969-05-22 1971-04-27 American Cyanamid Co N**2,n**4,n**6-trisubstituted melamines

Also Published As

Publication number Publication date
PT76470B (fr) 1986-03-11
FR2524467A1 (fr) 1983-10-07
ES521191A0 (es) 1984-06-01
PT76470A (fr) 1983-04-01
DE3361100D1 (en) 1985-12-05
IE830696L (en) 1983-09-30
ATE16286T1 (de) 1985-11-15
FR2524467B1 (xx) 1984-05-11
JPS58180482A (ja) 1983-10-21
EP0090733B1 (fr) 1985-10-30
CA1206150A (fr) 1986-06-17
IE55223B1 (en) 1990-07-04
US4514398A (en) 1985-04-30
OA07358A (fr) 1984-08-31
NZ203724A (en) 1985-12-13
AU1296783A (en) 1983-10-06
AU559376B2 (en) 1987-03-05
EP0090733A1 (fr) 1983-10-05
ES8405273A1 (es) 1984-06-01

Similar Documents

Publication Publication Date Title
ZA832214B (en) Disubstituted polymethylene-imines,processes for their preparation and pharmaceutical compositions containing them
TW221811B (xx)
ES8605806A1 (es) Procedimiento de preparacion de nuevos derivados de la xan- tina y de sus sales de adicion con acidos apropiados
DE3362022D1 (en) Xanthine derivatives, process for their preparation and pharmaceutical compositions containing them
ZA926276B (en) 2,4-thiazolidinedione compounds, process for preparing them and pharmaceutical compositions containing them.
IL75337A0 (en) Quinone derivative,process for the preparation thereof and pharmaceutical compositions containing the same
DE3361972D1 (en) N,n'-substituted polymethylene diamines, processes for their preparation and pharmaceutical compositions containing them
SE8300855L (sv) Nya piperazin- och homopiperazinderivat, forfaranden for framstellning derav och farmaceutiska kompositioner innehallande dem
EA200000261A3 (ru) Новые замещенные димерные соединения, способ их получения и содержащияся их фармацевтическая композиция
DK0434560T3 (da) Hidtil ukendte substituerede aminosyrederivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem